Drug Topics November 3, 2023
Skylar Jeremias

Speakers at an AMCP Nexus session provided an in-depth understanding of how changes brought on by the Inflation Reduction Act (IRA) have impacted Medicare, as well as what provisions are to come.

As the implementation of the Inflation Reduction Act (IRA) reaches its first anniversary, speakers at the Academy of Managed Care Pharmacy (AMCP) Nexus meeting recapped the changes that have taken place and mapped out the provisions still to come over the next several years.

Changes including out-of-pocket (OOP) caps for Medicare Part D drugs, price negotiations between Medicare and drug manufacturers, and the implementation of the Medicare Prescription Payment Plan (MPPP) will impact plans, pharmacy benefit managers (PBMs), and patients in different ways. The speakers stressed that collaboration...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Conferences / Podcast, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech, Trends
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article